Axa S.A. Aerie Pharmaceuticals Inc Transaction History

Axa S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$33.0 - $60.04 $5.71 Million - $10.4 Million	-173,120 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$47.85 - $70.45 $105,413 - $155,201	2,203 Added 1.29%	173,120 $11.7 Million
Q1 2018 May 14, 2018	SELL	$51.15 - $61.0 $88,540 - $105,591	-1,731 Reduced 1.0%	170,917 $9.27 Million
Q4 2017 Feb 13, 2018	SELL	$50.85 - $65.1 $1.68 Million - $2.15 Million	-33,069 Reduced 16.07%	172,648 $10.3 Million
Q3 2017 Nov 13, 2017	BUY	$48.6 - $60.1 $10 Million - $12.4 Million	205,717	205,717 $10 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.